A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa
- PMID: 20054342
- DOI: 10.1038/jid.2009.409
A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa
Abstract
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder that is associated with an inherited defect of the nucleotide excision repair pathway (NER). In this study, we investigated the involvement of XP genes in 86 XP patients belonging to 66 unrelated families, most of them consanguineous and originating from Maghreb. Sequencing analysis was performed either directly (44 probands) or after having previously characterized the involved XP gene by complementation assay (22 families). XPC and XPA mutations were respectively present in 56/66 and 8/66 probands. Strikingly, we identified the same homozygous frameshift mutation c.1643_1644delTG (p.Val548AlafsX25) in 87% of XP-C patients. Haplotype analysis showed a common founder effect for this mutation in the Mediterranean region, with an estimated age of 50 generations or 1,250 years. Among 7/8 XP-A patients, we found the previously reported nonsense homozygous XPA mutation (p.Arg228X). Six mutations--to our knowledge previously unreported--(five in XPC, one in XPA) were also identified. In conclusion, XPC appears to be the major disease-causing gene concerning xeroderma pigmentosum in North Africa. As the (p.Val548AlafsX25) XPC mutation is responsible for a huge proportion of XP cases, our data imply an obvious simplification of XP molecular diagnosis, at least in North Africa.
Comment in
-
Xeroderma pigmentosum: a heterogeneous disease with pockets of homogeneity.J Invest Dermatol. 2010 Jun;130(6):1484. doi: 10.1038/jid.2010.107. J Invest Dermatol. 2010. PMID: 20463670 No abstract available.
-
Founder mutations in xeroderma pigmentosum.J Invest Dermatol. 2010 Jun;130(6):1491-3. doi: 10.1038/jid.2010.76. J Invest Dermatol. 2010. PMID: 20463673 Free PMC article.
Similar articles
-
Founder mutations in xeroderma pigmentosum.J Invest Dermatol. 2010 Jun;130(6):1491-3. doi: 10.1038/jid.2010.76. J Invest Dermatol. 2010. PMID: 20463673 Free PMC article.
-
Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.Biomed Res Int. 2016;2016:2180946. doi: 10.1155/2016/2180946. Epub 2016 Jun 20. Biomed Res Int. 2016. PMID: 27413738 Free PMC article.
-
Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.J Dermatol. 2012 Apr;39(4):382-4. doi: 10.1111/j.1346-8138.2011.01453.x. Epub 2011 Dec 29. J Dermatol. 2012. PMID: 22211393
-
Xeroderma pigmentosum and molecular cloning of DNA repair genes.Anticancer Res. 1996 Mar-Apr;16(2):693-708. Anticancer Res. 1996. PMID: 8687116 Review.
-
Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease.Fetal Pediatr Pathol. 2015 Apr;34(2):120-7. doi: 10.3109/15513815.2014.982336. Epub 2014 Dec 2. Fetal Pediatr Pathol. 2015. PMID: 25454817 Review.
Cited by
-
Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family.Mol Genet Genomic Med. 2020 Feb;8(2):e1060. doi: 10.1002/mgg3.1060. Epub 2020 Jan 10. Mol Genet Genomic Med. 2020. PMID: 31923348 Free PMC article.
-
Founder mutations in xeroderma pigmentosum.J Invest Dermatol. 2010 Jun;130(6):1491-3. doi: 10.1038/jid.2010.76. J Invest Dermatol. 2010. PMID: 20463673 Free PMC article.
-
Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.Orphanet J Rare Dis. 2022 Mar 4;17(1):104. doi: 10.1186/s13023-022-02203-1. Orphanet J Rare Dis. 2022. PMID: 35246173 Free PMC article.
-
Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells.Nucleic Acids Res. 2017 Feb 17;45(3):1270-1280. doi: 10.1093/nar/gkw1196. Nucleic Acids Res. 2017. PMID: 28180309 Free PMC article.
-
Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.Blood. 2019 Jun 20;133(25):2718-2724. doi: 10.1182/blood-2019-01-895698. Epub 2019 Mar 26. Blood. 2019. PMID: 30914417 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials